148 related articles for article (PubMed ID: 7487957)
1. Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation.
Kronman C; Velan B; Marcus D; Ordentlich A; Reuveny S; Shafferman A
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):959-67. PubMed ID: 7487957
[TBL] [Abstract][Full Text] [Related]
2. Effect of human acetylcholinesterase subunit assembly on its circulatory residence.
Chitlaru T; Kronman C; Velan B; Shafferman A
Biochem J; 2001 Mar; 354(Pt 3):613-25. PubMed ID: 11237866
[TBL] [Abstract][Full Text] [Related]
3. Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels.
Chitlaru T; Kronman C; Zeevi M; Kam M; Harel A; Ordentlich A; Velan B; Shafferman A
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):647-58. PubMed ID: 9841877
[TBL] [Abstract][Full Text] [Related]
4. Overloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time.
Chitlaru T; Kronman C; Velan B; Shafferman A
Biochem J; 2002 May; 363(Pt 3):619-31. PubMed ID: 11964163
[TBL] [Abstract][Full Text] [Related]
5. Bovine acetylcholinesterase: cloning, expression and characterization.
Mendelson I; Kronman C; Ariel N; Shafferman A; Velan B
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):251-9. PubMed ID: 9693127
[TBL] [Abstract][Full Text] [Related]
6. Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase.
Saxena A; Raveh L; Ashani Y; Doctor BP
Biochemistry; 1997 Jun; 36(24):7481-9. PubMed ID: 9200697
[TBL] [Abstract][Full Text] [Related]
7. Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta).
Cohen O; Kronman C; Velan B; Shafferman A
Biochem J; 2004 Feb; 378(Pt 1):117-28. PubMed ID: 14575524
[TBL] [Abstract][Full Text] [Related]
8. Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases.
Saxena A; Ashani Y; Raveh L; Stevenson D; Patel T; Doctor BP
Mol Pharmacol; 1998 Jan; 53(1):112-22. PubMed ID: 9443938
[TBL] [Abstract][Full Text] [Related]
9. Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase.
Kronman C; Chitlaru T; Elhanany E; Velan B; Shafferman A
J Biol Chem; 2000 Sep; 275(38):29488-502. PubMed ID: 10867010
[TBL] [Abstract][Full Text] [Related]
10. igh sialic acid content slows prourokinase turnover in rabbits.
Henkin J; Dudlak D; Beebe DP; Sennello L
Thromb Res; 1991 Jul; 63(2):215-25. PubMed ID: 1771627
[TBL] [Abstract][Full Text] [Related]
11. Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity.
Cohen O; Kronman C; Chitlaru T; Ordentlich A; Velan B; Shafferman A
Biochem J; 2001 Aug; 357(Pt 3):795-802. PubMed ID: 11463350
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulation.
Richards AA; Colgrave ML; Zhang J; Webster J; Simpson F; Preston E; Wilks D; Hoehn KL; Stephenson M; Macdonald GA; Prins JB; Cooney GJ; Xu A; Whitehead JP
Mol Endocrinol; 2010 Jan; 24(1):229-39. PubMed ID: 19855092
[TBL] [Abstract][Full Text] [Related]
13. Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics.
Kronman C; Cohen O; Mazor O; Ordentlich A; Raveh L; Velan B; Shafferman A
Chem Biol Interact; 2010 Sep; 187(1-3):253-8. PubMed ID: 20005217
[TBL] [Abstract][Full Text] [Related]
14. Three N-Glycosylation Sites of Human Acetylcholinesterase Shares Similar Glycan Composition.
Xu ML; Luk WK; Lau KM; Bi CW; Cheng AW; Gong AG; Lin H; Tsim KW
J Mol Neurosci; 2015 Dec; 57(4):486-91. PubMed ID: 26231935
[TBL] [Abstract][Full Text] [Related]
15. In vivo bioactivities and clearance patterns of highly purified human luteinizing hormone isoforms.
Burgon PG; Stanton PG; Robertson DM
Endocrinology; 1996 Nov; 137(11):4827-36. PubMed ID: 8895353
[TBL] [Abstract][Full Text] [Related]
16. Controlled concealment of exposed clearance and immunogenic domains by site-specific polyethylene glycol attachment to acetylcholinesterase hypolysine mutants.
Cohen O; Kronman C; Lazar A; Velan B; Shafferman A
J Biol Chem; 2007 Dec; 282(49):35491-501. PubMed ID: 17932038
[TBL] [Abstract][Full Text] [Related]
17. Host-regulated disposition of mammalian AChEs.
Kronman C; Cohen O; Velan B; Shafferman A
Chem Biol Interact; 2005 Dec; 157-158():51-5. PubMed ID: 16289063
[TBL] [Abstract][Full Text] [Related]
18. Complete amino acid sequence of fetal bovine serum acetylcholinesterase and its comparison in various regions with other cholinesterases.
Doctor BP; Chapman TC; Christner CE; Deal CD; De La Hoz DM; Gentry MK; Ogert RA; Rush RS; Smyth KK; Wolfe AD
FEBS Lett; 1990 Jun; 266(1-2):123-7. PubMed ID: 2365060
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation site Asn168 is important for slow in vivo clearance of recombinant human diamine oxidase heparin-binding motif mutants.
Gludovacz E; Resch M; Schuetzenberger K; Petroczi K; Maresch D; Hofbauer S; Jilma B; Borth N; Boehm T
Glycobiology; 2022 Apr; 32(5):404-413. PubMed ID: 35088086
[TBL] [Abstract][Full Text] [Related]
20. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
